✦ LIBER ✦

Drug development in patients with advanced non-small cell lung cancer and poor performance status

✍ Scribed by Thomas E. Stinchcombe; Mark A. Socinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment approaches in patients with ad

✍ Ramaswamy Govindan; David H. Garfield 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Role of chemotherapy in patients with po

✍ Corey Langer; Rogerio Lilenbaum 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Carboplatin-based chemotherapy in patien

✍ Stinchcombe, Thomas E.; Choi, Jaeun; Schell, Michael J.; Mears, Andrea; Jones, P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Management of patients with non-small ce

✍ Ramaswamy Govindan 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 194 KB

Activity of gefitinib in advanced non-sm

✍ Gee-Chen Chang; Kun-Chieh Chen; Tsung-Ying Yang; Ming-Chang Yin; Ching-Pei Lin; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 54 KB

Challenges in defining and identifying p

✍ Karen Kelly 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 101 KB